Across TCGA pan-cancer cohorts, RPS29 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RPS29 data layer compared with 25 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RPS29 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RPS29 expression acts as an unfavorable survival marker.

UCEC are the cancer types where RPS29 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RPS29 tumor-vs-normal RNA expression · all RPS29 data types